Skip to main content
SpringerLink
Log in

Cannabinoide im täglichen Einsatz: Evidenz – Realität – Vision

Cannabinoids in Daily Use. Evidence—Reality—Vision

  • Aktuelles
  • Published:
Journal für Gynäkologische Endokrinologie/Österreich Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Verkaufsverbot von CBD-haltigen Lebensmittel und Kosmetika. Presseaussendung, 9. Dez. 2018

  2. Hua T et al (2016) Crystal structure of the human Cannabinoid receptor CB1. Cell 167(3):750–762.e1. https://doi.org/10.1016/j.cell.2016.10.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ashton JC, Wright JL, McPartland JM, Tyndall JD (2008) Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Curr Med Chem 15(14):1428–1443

    Article  CAS  Google Scholar 

  4. Diniz CRAF et al (2019) Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors. PeerJ 7:e6493

    Article  Google Scholar 

  5. Compassionat Use Act 1996—California Proposition 215/2016 Medical Cannabis Regulation and Safty Act

  6. Pinsger M, Schimetta W, Volc D et al (2006) Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie. Wien Klin Wochenschr 118:327

    Article  Google Scholar 

  7. National Academies of Sciences, Engineering, and Medicine (2017) The health effects of cannabis and Cannabinoides. The current state of evidence and recommendations for research. The National Academies Press, Washington, DC https://doi.org/10.17226/24625

    Book  Google Scholar 

  8. Leitlinien Deutsche Schmerzgesellschaft Cannabis 2018

  9. Bakali E et al (2016) Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. Int Urogynecol J 27(9):1393–1400

    Article  Google Scholar 

  10. Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 163(7):1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Philpott HT, O’Brien M, McDougall JJ (2017) Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain 158(12):2442–2451

    Article  CAS  Google Scholar 

  12. Arznei-news.de (2018) Cannabidiol (Epidiolex) – Tuberöse Sklerose. https://arznei-news.de/cannabidiol4-tuberoese-sklerose/ (Erstellt: 1. März 2018). Zugegriffen: 26. Okt. 2018

    Google Scholar 

  13. McPartland JM (2002) Receptor evolution, sourcing the code. J Cannabis Ther 2(1):73–2013

    Article  CAS  Google Scholar 

  14. Peciña S et al (2006) Hedonic hot spots in the brain. Neuroscientist 12(6):500–511

    Article  Google Scholar 

  15. Zhu PJ (2006) Endocannabinoid signaling and synaptic plasticity in the brain. Crit Rev Neurobiol 18(1–2):113–124

    Article  CAS  Google Scholar 

  16. Kendall D, Alexander S (2017) Cannabinoid Pharmacology. Advances in Pharmacology, Bd. 80. Academic Press, Cambridge

    Book  Google Scholar 

  17. Flores A, Maldonado R, Berrendero F (2013) Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 7:256. https://doi.org/10.3389/fnins.2013.00256

    Article  PubMed  PubMed Central  Google Scholar 

  18. Skosnik PD, Cortes-Briones JA, Hajós M (2016) It’s all in the rhythm: the role of Cannabinoids in neural oscillations and psychosis. Biol Psychiatry 79(7):568–577. https://doi.org/10.1016/j.biopsych.2015.12.011

    Article  CAS  PubMed  Google Scholar 

  19. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418(6897):530–534

    Article  CAS  Google Scholar 

  20. International Narcotic Controll Board 2018 Annual Report: with special focus on the risks and benefits of medical use of cannabis

  21. Abela AR, Rahbarnia A, Wood S, Lê AD, Fletcher PJ (2019) Adolescent exposure to ∆9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood. Psychopharmacology (Berl). https://doi.org/10.1007/s00213-019-5171-1

    Article  Google Scholar 

  22. Med Ahead, Cannabinoide medizinisch nutzen. 2010 www.oesg.at, Aussage Prof. Beubler

Download references

Author information

Authors and Affiliations

  1. Schmerzkompetenzzentrum, Badnerstraße 8, 2540, Bad Vöslau, Österreich

    Martin Pinsger

Authors
  1. Martin Pinsger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Pinsger.

Ethics declarations

Interessenkonflikt

M. Pinsger gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinsger, M. Cannabinoide im täglichen Einsatz: Evidenz – Realität – Vision. J. Gynäkol. Endokrinol. AT 29, 45–48 (2019). https://doi.org/10.1007/s41974-019-0090-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41974-019-0090-z

Search

Navigation